Xiaoliang Guo

Dr. Xiaoliang Guo


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2023 in Energy Sources, Part A: Recovery, Utilization, and Environmental Effects
Verified
Journal Article
Closed access
BLBo Li
Bo Li
XGXiaoliang Guo
Xiaoliang Guo
TLTianyang Li
Tianyang Li
YLYu-Tao Li
Yu-Tao Li

28 July 2025 in Expert Systems with Applications
Verified
Journal Article
Closed access
SZShuo Zhai
Shuo Zhai
XGXiaoliang Guo
Xiaoliang Guo

13 January 2025 in Cognitive Neurodynamics
Verified
Journal Article
Closed access
PDF file
XGXiaoliang Guo
Xiaoliang Guo
SZShuo Zhai
Shuo Zhai

20 October 2023
Verified
Conference Paper
Open access
JWJiandong Wang
Jiandong Wang
XGXiaoliang Guo
Xiaoliang Guo
LSLiujia Shi
Liujia Shi
YTYingjun Tan
Yingjun Tan
This paper describes a new circuit system for cell manipulation, cell electroporation and cell impedance measurement based on cell microarray chips and provides an integrated and miniaturized scheme for cell research. By applying two reversed sinusoidal excitation signals to the circular electrode, the cells on the electrode can be made to move under the action of dielectrophoresis force. After moving the cell to the central measuring electrode, we can apply a pulse to the cell to achive electroporation or apply a small sinusoidal signal to the cell to measure impedance. Due to the fact that cells can only withstand small voltage signals and these signals are easily affected by noise, this paper uses Labview to implement a phase-locked loop algorithm to extract the small signal feedback from the original signal. Then, various functions of the circuit system were verified by taking Huh7 liver cancer cell suspension as the object, and check test was carried out using electrochemical workstation parstat 4000a.

23 June 2026 in iScience
Verified
Journal Article
Open access
RCRenyu Chen
Renyu Chen
BYBohui Yin
Bohui Yin
YZYaowei Zhang
Yaowei Zhang
JPJunya Peng
Junya Peng
XGXiaoliang Guo
Xiaoliang Guo
WWWenming Wu
Wenming Wu
Pancreatic ductal adenocarcinoma (PDAC) remains lethal due to late-stage diagnosis and limited non-surgical treatment options. Its intratumoral heterogeneity and desmoplastic tumor microenvironment (TME) drive invasion, immune escape, and treatment failure. Patient-derived organoids (PDOs) have emerged as efficient model platforms for simulating the TME and preserving tumor heterogeneity and enabling functional testing in vitro; however, conventional PDO cultures lack defined and controllable microenvironmental components and often exhibited limited reproducibility, physiological fidelity, and observability. This review synthesizes recent bioengineering advances that upgrade pancreatic cancer PDO platforms across three interconnected dimensions: (1) engineered extracellular matrices and biofabrication for reproducible construction; (2) co-culture, microfluidic, and bioreactor systems for physiological fidelity; (3) imaging AI and biosensor pipelines for quantitative monitoring. We highlight practical design principles and remaining bottlenecks for standardization, scalability, and clinical translation.

25 April 2026 in Talanta
Verified
Journal Article
Closed access
BLBo Li
Bo Li
XGXiaoliang Guo
Xiaoliang Guo
JYJialin Yao
Jialin Yao